After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Cardio Diagnostics Holdings Inc. (CDIO) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.01, or -0.22%, to $4.59. The Cardio Diagnostics Holdings Inc. has recorded 37,291 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Cardio Diagnostics Holdings, Inc Announces Financing Agreement with Yorkville Advisors Global, LP of up to $11.2 Million.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Stocks Info
Cardio Diagnostics Holdings Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $4.60 and fluctuated between $5.3500 as its day high and $4.5101 as its day low. The current market capitalization of Cardio Diagnostics Holdings Inc. is $50.28M. A total of 0.55 million shares were traded on the day, compared to an average of 3.95M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, CDIO has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 1 SELLs from insiders. Insiders purchased 0 shares during that period but sold 1,565,000.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for CDIO in the last 3 months, the mean price target is $8.00 with high estimates of $8.00 and low estimates of $8.00. In terms of 52-week highs and lows, CDIO has a high of $10.25 and a low of $0.80.
As of this writing, CDIO has an earnings estimate of -$0.09 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.09 per share and a lower estimate of -$0.09.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CDIO’s latest balance sheet shows that the firm has $512.77k in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $8.02, while its Total Shareholder’s Equity was $1.07M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 1 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDIO is Buy with a score of 5.00. A total of 1 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.
